Jenny Shammai

Title: Jenny Shammai: Innovator in Pharmaceutical Synthesis

Introduction

Jenny Shammai is a prominent inventor based in Kiryat Yam, Israel. She has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of bicalutamide, a medication used in the treatment of prostate cancer. With a total of five patents to her name, her work has had a substantial impact on the pharmaceutical industry.

Latest Patents

Jenny Shammai's latest patents focus on innovative processes for the synthesis of racemic and optically active bicalutamide. These processes begin with ethyl pyruvate and methyl methacrylate, leading to the preparation of various bicalutamide intermediates. Her inventions include the synthesis of ethyl-[2-{4-fluorophenyl sulfone}]-2-hydroxy propionate, 1,2-epoxy-2-methyl propionate, and 2-hydrox-2-methyl-3-(4-fluorophenylthio) propionic acid. Additionally, she has developed methods for the isolation and purification of racemic and optically active bicalutamide, as well as micronized forms of the compound.

Career Highlights

Throughout her career, Jenny has worked with notable companies in the pharmaceutical sector, including Biogal Gyógyszergyár Rt. Her expertise in the field has allowed her to contribute to the advancement of drug synthesis and development.

Collaborations

Jenny has collaborated with esteemed colleagues such as Ben-Zion Dolitzky and Ofer Reany. These partnerships have further enhanced her research and innovation in pharmaceutical synthesis.

Conclusion

Jenny Shammai is a trailblazer in the field of pharmaceutical synthesis, with a focus on bicalutamide. Her innovative processes and collaborations have significantly contributed to advancements in medication development. Her work continues to influence the pharmaceutical industry positively.